These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 21858962

  • 1. The world of the Haight-Ashbury speed freak.
    Smith RC, Crim D.
    J Psychoactive Drugs; 2011; 43(2):165-71. PubMed ID: 21858962
    [No Abstract] [Full Text] [Related]

  • 2. Psychedelic drugs, hippie counterculture, speed and phenobarbital treatment of sedative-hypnotic dependence: a journey to the Haight Ashbury in the Sixties.
    Wesson DR.
    J Psychoactive Drugs; 2011; 43(2):153-64. PubMed ID: 21858961
    [Abstract] [Full Text] [Related]

  • 3. Patterns of drug use in the Haight-Ashbury neighborhood.
    Shick JF, Smith DE, Meyers FH.
    Clin Toxicol; 1970 Mar; 3(1):19-56. PubMed ID: 4398601
    [No Abstract] [Full Text] [Related]

  • 4. Clinical effects and management of methamphetamine abuse.
    Romanelli F, Smith KM.
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [Abstract] [Full Text] [Related]

  • 5. A controlled trial of imipramine for the treatment of methamphetamine dependence.
    Galloway GP, Newmeyer J, Knapp T, Stalcup SA, Smith D.
    J Subst Abuse Treat; 1996 Aug; 13(6):493-7. PubMed ID: 9219147
    [Abstract] [Full Text] [Related]

  • 6. Before and after pictures: A time honoured way of oversimplifying complex problems.
    Baillie DW, Salter M.
    BMJ; 2007 Jul 07; 335(7609):8. PubMed ID: 17615193
    [No Abstract] [Full Text] [Related]

  • 7. California Substance Abuse Research Consortium, September 2005: update on recent methamphetamine trends in four California regions.
    Rutkowski BA.
    J Psychoactive Drugs; 2006 Nov 07; Suppl 3():369-75. PubMed ID: 17357528
    [Abstract] [Full Text] [Related]

  • 8. From Hofmann to the Haight Ashbury, and into the future: the past and potential of lysergic acid diethlyamide.
    Smith DE, Raswyck GE, Davidson LD.
    J Psychoactive Drugs; 2014 Nov 07; 46(1):3-10. PubMed ID: 24830180
    [Abstract] [Full Text] [Related]

  • 9. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine.
    Vearrier D, Greenberg MI, Miller SN, Okaneku JT, Haggerty DA.
    Dis Mon; 2012 Feb 07; 58(2):38-89. PubMed ID: 22251899
    [No Abstract] [Full Text] [Related]

  • 10. Reasons for stimulant use among Latino gay men in San Francisco: a comparison between methamphetamine and cocaine users.
    Díaz RM, Heckert AL, Sánchez J.
    J Urban Health; 2005 Mar 07; 82(1 Suppl 1):i71-8. PubMed ID: 15738318
    [Abstract] [Full Text] [Related]

  • 11. 'Ice epidemic'? Trends in methamphetamine use from three Victorian surveillance systems.
    Lim MS, Cogger S, Quinn B, Hellard ME, Dietze PM.
    Aust N Z J Public Health; 2015 Apr 07; 39(2):194-5. PubMed ID: 25559677
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of methamphetamine abuse beyond individual users.
    Watanabe-Galloway S, Ryan S, Hansen K, Hullsiek B, Muli V, Malone AC.
    J Psychoactive Drugs; 2009 Sep 07; 41(3):241-8. PubMed ID: 19999677
    [Abstract] [Full Text] [Related]

  • 15. Methamphetamine and driving.
    Lemos NP.
    Sci Justice; 2009 Dec 07; 49(4):247-9. PubMed ID: 20120602
    [Abstract] [Full Text] [Related]

  • 16. Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004-2006.
    Marquez C, Mitchell SJ, Hare CB, John M, Klausner JD.
    AIDS Care; 2009 May 07; 21(5):575-82. PubMed ID: 19444665
    [Abstract] [Full Text] [Related]

  • 17. A comparison of injecting and noninjecting methamphetamine users.
    Domier CP, Simon SL, Rawson RA, Huber A, Ling W.
    J Psychoactive Drugs; 2000 May 07; 32(2):229-32. PubMed ID: 10908012
    [Abstract] [Full Text] [Related]

  • 18. Deterioration of intelligence in methamphetamine-induced psychosis: comparison with alcohol dependence on WAIS-III.
    Lin SK, Huang MC, Lin HC, Pan CH.
    Psychiatry Clin Neurosci; 2010 Feb 07; 64(1):4-9. PubMed ID: 19968830
    [Abstract] [Full Text] [Related]

  • 19. When treatment meets research: clinical perspectives from the CSAT Methamphetamine Treatment Project.
    Obert JL, Brown AH, Zweben J, Christian D, Delmhorst J, Minsky S, Morrisey P, Vandersloot D, Weiner A.
    J Subst Abuse Treat; 2005 Apr 07; 28(3):231-7. PubMed ID: 15857723
    [Abstract] [Full Text] [Related]

  • 20. Methamphetamine and psychiatry: A story of the colourless substance of abuse.
    Suetani S, Reddan J, Anderson C.
    Australas Psychiatry; 2017 Jun 07; 25(3):254-256. PubMed ID: 28541728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.